California state Sen. Jeff Stone, a former independent pharmacist himself, had one message for independent pharmacists during the McKesson ideaShare 2015 Public Policy session in San Diego — don’t just vote, get involved.
The guidance was outlined in a blog post by Janet Woodcock, director of the FDA’s center for drug evaluation and research, and Karen Midthum, director of the FDA’s center for biologics evaluation and research.
Vermont on Friday became the last state in the nation to legalize electronic prescriptions for controlled substances — a measure that many states have adopted as a way to combat the abuse of controlled substances and prevent individuals from resorting to fraudulent paper prescriptions.
The National Association of Chain Drugs Stores celebrated Albertsons/Safeway and Kinney Drugs for the companies’ political advocacy and grassroots activities at NACDS Total Store Expo, Friday evening at the NACDS Political Involvement reception.
NACDS president and CEO Steve Anderson discusses the NACDS RxImpact grassroots advocacy program, which can serve as a resource for pharmacy professionals to learn how to engage and educate lawmakers about key pharmacy issues.
“A profound, and likely irreversible, impact on the business of health care.” That’s the effect the Patient Protection and Affordable Care Act already has had in the five years since its passage and enactment into law, PricewaterhouseCoopers said.
Variations in how states have implemented the insurance eligibility provisions of the Affordable Care Act have “led to highly diverse, geographically dependent health reform experiences,” noted PwC’s Health Research Institute, and made the states “key players in health reform.”